GCP
GLSI icon

GSA Capital Partners’s Greenwich LifeSciences GLSI Stock Holding History

GSA Capital Partners’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$458K Buy
+19,543
New +$476K 0.03% 1060
2023
Q4 		– Sell
-45,850
Closed -$405K – 1658
2023
Q3 		$405K Buy
45,850
+12,441
+37% +$117K 0.03% 918
2023
Q2 		$322K Buy
33,409
+20,751
+164% +$232K 0.03% 1008
2023
Q1 		$175K Sell
12,658
-120
-0.9% -$1.9K 0.02% 1284
2022
Q4 		$194K Buy
+12,778
New +$146K 0.02% 1195

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

GSA Capital Partners's GLSI Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Greenwich LifeSciences (GLSI) in Q2 2026: 19,543 shares worth $458K. The stake represents 0.03% of the portfolio and ranks #1060 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in GLSI as recently as Q3 2023.

GSA Capital Partners first reported a position in GLSI in Q4 2022 and has held it in 5 quarters since. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • GSA Capital Partners held 19,543 shares of Greenwich LifeSciences worth $458K as of Q2 2026.
  • Greenwich LifeSciences was a new GSA Capital Partners position in Q2 2026.
  • Greenwich LifeSciences made up 0.03% of GSA Capital Partners's portfolio in Q2 2026, its #1060 holding.
  • GSA Capital Partners first reported a position in Greenwich LifeSciences in Q4 2022 and has held it in 5 quarters since.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.